Phase 1 Study of HSVTK-CD34 Modified T Cells Therapy Following Haematopoietic Stem Cell Transplantation (HSCT) without Serotherapy (2012)

First Author: Zhan Hong
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Volume: 20

Parent Publication: MOLECULAR THERAPY

ISSN: 1525-0016